Alcon Inc. Logo

Alcon Inc.

ALC.SW

(2.0)
Stock Price

75,12 CHF

9.16% ROA

5.34% ROE

42.94x PER

Market Cap.

47.199.738.804,96 CHF

24.3% DER

0.25% Yield

11.44% NPM

Alcon Inc. Stock Analysis

Alcon Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Alcon Inc. Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a low debt to equity ratio (26%), which means it has a small amount of debt compared to the ownership it holds

2 ROE

The stock's ROE falls within an average range (1.84%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

3 ROA

The stock's ROA (3.43%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

4 PBV

The stock's PBV ratio (1.77x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

5 Assets Growth

Over the past three years, this company's revenue has consistently grown, demonstrating a positive financial trend that makes it an appealing choice.

6 Dividend

The company's consistent dividend payments over the past three years indicate a strong commitment to delivering returns to investors.

7 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is undervalued (1.324), making it an appealing investment prospect with its intrinsic value surpassing the current market price.

8 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

9 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

10 Graham Number

The Graham number calculation reveals that this company's stock price is potentially inflated, implying that it may not be a desirable investment option.

11 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

Alcon Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Alcon Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Hold

Alcon Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Alcon Inc. Revenue
Year Revenue Growth
2015 6.776.000.000
2016 6.596.000.000 -2.73%
2017 6.792.000.000 2.89%
2018 7.276.000.000 6.65%
2019 7.508.000.000 3.09%
2020 6.833.000.000 -9.88%
2021 8.291.000.000 17.59%
2022 8.717.000.000 4.89%
2023 9.316.000.000 6.43%
2023 9.455.000.000 1.47%
2024 9.984.000.000 5.3%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Alcon Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2015 965.000.000
2016 499.000.000 -93.39%
2017 584.000.000 14.55%
2018 587.000.000 0.51%
2019 656.000.000 10.52%
2020 673.000.000 2.53%
2021 842.000.000 20.07%
2022 702.000.000 -19.94%
2023 804.000.000 12.69%
2023 828.000.000 2.9%
2024 880.000.000 5.91%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Alcon Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2015 0
2016 2.526.000.000 100%
2017 2.596.000.000 2.7%
2018 2.801.000.000 7.32%
2019 2.847.000.000 1.62%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Alcon Inc. EBITDA
Year EBITDA Growth
2015 1.721.000.000
2016 1.289.000.000 -33.51%
2017 1.225.000.000 -5.22%
2018 1.353.000.000 9.46%
2019 1.226.000.000 -10.36%
2020 1.115.000.000 -9.96%
2021 1.757.000.000 36.54%
2022 1.720.000.000 -2.15%
2023 1.140.000.000 -50.88%
2023 2.294.000.000 50.31%
2024 2.564.000.000 10.53%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Alcon Inc. Gross Profit
Year Gross Profit Growth
2015 3.249.000.000
2016 3.111.000.000 -4.44%
2017 3.204.000.000 2.9%
2018 3.192.000.000 -0.38%
2019 3.662.000.000 12.83%
2020 2.940.000.000 -24.56%
2021 4.652.000.000 36.8%
2022 4.748.000.000 2.02%
2023 5.156.000.000 7.91%
2023 5.247.000.000 1.73%
2024 5.496.000.000 4.53%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Alcon Inc. Net Profit
Year Net Profit Growth
2015 308.000.000
2016 -170.000.000 281.18%
2017 256.000.000 166.41%
2018 -315.000.000 181.27%
2019 -656.000.000 51.98%
2020 -531.000.000 -23.54%
2021 376.000.000 241.22%
2022 335.000.000 -12.24%
2023 816.000.000 58.95%
2023 974.000.000 16.22%
2024 892.000.000 -9.19%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Alcon Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2015 0
2016 0 0%
2017 1 0%
2018 -1 0%
2019 -1 100%
2020 -1 0%
2021 1 0%
2022 1 0%
2023 2 100%
2023 2 0%
2024 2 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Alcon Inc. Free Cashflow
Year Free Cashflow Growth
2015 924.000.000
2016 739.000.000 -25.03%
2017 722.000.000 -2.35%
2018 428.000.000 -68.69%
2019 244.000.000 -75.41%
2020 256.000.000 4.69%
2021 165.000.000 -55.15%
2022 472.000.000 65.04%
2023 537.000.000 12.1%
2024 410.000.000 -30.98%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Alcon Inc. Operating Cashflow
Year Operating Cashflow Growth
2015 1.370.000.000
2016 1.245.000.000 -10.04%
2017 1.218.000.000 -2.22%
2018 1.140.000.000 -6.84%
2019 920.000.000 -23.91%
2020 823.000.000 -11.79%
2021 1.345.000.000 38.81%
2022 1.217.000.000 -10.52%
2023 1.388.000.000 12.32%
2024 530.000.000 -161.89%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Alcon Inc. Capital Expenditure
Year Capital Expenditure Growth
2015 446.000.000
2016 506.000.000 11.86%
2017 496.000.000 -2.02%
2018 712.000.000 30.34%
2019 676.000.000 -5.33%
2020 567.000.000 -19.22%
2021 1.180.000.000 51.95%
2022 745.000.000 -58.39%
2023 851.000.000 12.46%
2024 120.000.000 -609.17%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Alcon Inc. Equity
Year Equity Growth
2015 23.637.000.000
2016 23.012.000.000 -2.72%
2017 23.029.000.000 0.07%
2018 19.515.000.000 -18.01%
2019 19.303.000.000 -1.1%
2020 18.822.000.000 -2.56%
2021 19.256.000.000 2.25%
2022 19.677.000.000 2.14%
2023 20.624.000.000 4.59%
2024 20.941.000.000 1.51%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Alcon Inc. Assets
Year Assets Growth
2015 28.202.000.000
2016 27.740.000.000 -1.67%
2017 27.388.000.000 -1.29%
2018 27.301.000.000 -0.32%
2019 27.655.000.000 1.28%
2020 27.600.000.000 -0.2%
2021 27.999.000.000 1.43%
2022 29.209.000.000 4.14%
2023 29.614.000.000 1.37%
2024 29.718.000.000 0.35%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Alcon Inc. Liabilities
Year Liabilities Growth
2015 4.565.000.000
2016 4.728.000.000 3.45%
2017 4.359.000.000 -8.47%
2018 7.786.000.000 44.01%
2019 8.352.000.000 6.78%
2020 8.778.000.000 4.85%
2021 8.743.000.000 -0.4%
2022 9.532.000.000 8.28%
2023 8.990.000.000 -6.03%
2024 8.777.000.000 -2.43%

Alcon Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
19.49
Net Income per Share
2.23
Price to Earning Ratio
42.94x
Price To Sales Ratio
4.9x
POCF Ratio
25.59
PFCF Ratio
41.15
Price to Book Ratio
2.26
EV to Sales
5.28
EV Over EBITDA
28.02
EV to Operating CashFlow
27.54
EV to FreeCashFlow
44.39
Earnings Yield
0.02
FreeCashFlow Yield
0.02
Market Cap
47,20 Bil.
Enterprise Value
50,92 Bil.
Graham Number
46.08
Graham NetNet
-9.81

Income Statement Metrics

Net Income per Share
2.23
Income Quality
1.68
ROE
0.05
Return On Assets
0.04
Return On Capital Employed
0.04
Net Income per EBT
1.08
EBT Per Ebit
0.86
Ebit per Revenue
0.12
Effective Tax Rate
-0.08

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0.09
Stock Based Compensation to Revenue
0.02
Gross Profit Margin
0.55
Operating Profit Margin
0.12
Pretax Profit Margin
0.11
Net Profit Margin
0.11

Dividends

Dividend Yield
0
Dividend Yield %
0.25
Payout Ratio
0
Dividend Per Share
0.24

Operating Metrics

Operating Cashflow per Share
3.74
Free CashFlow per Share
2.32
Capex to Operating CashFlow
0.38
Capex to Revenue
0.07
Capex to Depreciation
0.57
Return on Invested Capital
0.05
Return on Tangible Assets
0.09
Days Sales Outstanding
70.04
Days Payables Outstanding
73.66
Days of Inventory on Hand
197.9
Receivables Turnover
5.21
Payables Turnover
4.96
Inventory Turnover
1.84
Capex per Share
1.42

Balance Sheet

Cash per Share
2,77
Book Value per Share
42,35
Tangible Book Value per Share
6.58
Shareholders Equity per Share
42.35
Interest Debt per Share
10.67
Debt to Equity
0.24
Debt to Assets
0.17
Net Debt to EBITDA
2.05
Current Ratio
2.56
Tangible Asset Value
3,26 Bil.
Net Current Asset Value
-2,79 Bil.
Invested Capital
26019000000
Working Capital
3,65 Bil.
Intangibles to Total Assets
0.6
Average Receivables
1,84 Bil.
Average Payables
0,84 Bil.
Average Inventory
2325500000
Debt to Market Cap
0.11

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Alcon Inc. Dividends
Year Dividends Growth
2020 0
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Alcon Inc. Profile

About Alcon Inc.

Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under the PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

CEO
Mr. David J. Endicott
Employee
25.000
Address
Chemin de Blandonnet 8
Geneva, 1214

Alcon Inc. Executives & BODs

Alcon Inc. Executives & BODs
# Name Age
1 Mr. Ian Bell
Senior Vice President & Chief Operating Officer
70
2 Dr. Franck Leveiller
Senior Vice President, Head of Global R&D and Chief Scientific Officer
70
3 Margaret Buckley
Chief Accounting Officer
70
4 Mr. Laurent Attias
Head of Corporate Development, Strategy, BD&L and M&A
70
5 Mr. Arthur B. Cummings M.D.
Executive Director
70
6 Ms. Kimberly Martin
Senior Vice President, Chief HR Officer & Corporate Communications
70
7 Mr. Royce R. Bedward
Senior Vice President, General Counsel & Corporate Secretary
70
8 Mr. David J. Endicott
Chief Executive Officer & Director
70
9 Mr. F. Michael Ball
Executive Chairman
70
10 Mr. Timothy C. Stonesifer
Chief Financial Officer
70

Alcon Inc. Competitors

Novartis AG Logo
Novartis AG

NOVN.SW

(2.5)
Givaudan SA Logo
Givaudan SA

GIVN.SW

(3.2)
Lonza Group AG Logo
Lonza Group AG

LONN.SW

(2.5)
ABB Ltd Logo
ABB Ltd

ABBN.SW

(2.2)
Swiss Life Holding AG Logo
Swiss Life Holding AG

SLHN.SW

(2.8)